Publications by authors named "Jun Anabuki"

Claim this Profile
A
Antipsychotic-like effects of a novel phosphodiesterase 10A inhibitor MT-3014 in rats.
Misae Takakuwa, Yumi Watanabe, Takeaki Saijo, Meguru Murata, Jun Anabuki

Pharmacol Biochem Behav· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations.
Sayaka Fukuda-Tsuru, Jun Anabuki, Yuji Abe, Kumiko Yoshida, Shinichi Ishii

Eur J Pharmacol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Tomohiro Yoshida, Fumihiko Akahoshi, Hiroshi Sakashita, Hiroshi Kitajima, Mitsuharu Nakamura, Jun Anabuki

Bioorg Med Chem· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis